Temozolomide for malignant brain tumours

Lancet. 2000 Apr 1;355(9210):1115-6. doi: 10.1016/S0140-6736(00)02055-9.
No abstract available

MeSH terms

  • Antineoplastic Agents, Alkylating / therapeutic use*
  • Brain Neoplasms / drug therapy*
  • Brain Neoplasms / mortality
  • Clinical Trials as Topic
  • Dacarbazine / analogs & derivatives*
  • Dacarbazine / therapeutic use
  • Glioblastoma / drug therapy*
  • Glioblastoma / mortality
  • Glioma / drug therapy*
  • Glioma / mortality
  • Humans
  • Temozolomide
  • United States / epidemiology

Substances

  • Antineoplastic Agents, Alkylating
  • Dacarbazine
  • Temozolomide